Albumin in Acute Variceal Bleeding

Starting soon · Phase 3

Conditions studied: Acute Variceal Bleeding, Cirrhosis

In brief

The objective of this randomized control clinical trial is to learn the role of albumin in patients with acute variceal bleed. The trial will include all adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, U.P. India, will include patients with age between 18-70 years and all gender. The primary endpoint will be re-bleeding during hospitalization and at 6 weeks. Participants will be randomized in two groups, the intervention group will receive albumin for 3 days along with standard treatment and comparison group will receive on standard treatment.

Key facts

Study ID

NCT07395141

Run by

King George's Medical University

People needed

60

Starts

2026-03-01

Expected to finish

2026-05-31

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, U.P. India.

You may not qualify if…

• Age < 18 years and > 70 years
• Patients with portal vein thrombosis
• Hepatocellular carcinoma
• Non-cirrhotic portal fibrosis
• Extrahepatic portal vein thrombosis
• Patients who received albumin in the last one month
• Patients who require fresh frozen plasma
• Patients with heart failure
• Patients with chronic kidney disease
• Volume overload state

Where it is running

• Dr Sumit Rungta — Lucknow, Uttar Pradesh, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.